glp 1 for high blood pressure GLP-1 drugs tied to risks in certain patients, study finds glp-1 and high blood pressure
Description
In STEP-1, participants taking semaglutide 2.4mg weekly lost an average of 14.9% of body weight over 68 weeks
metformin 1000 mg BID led to conflicting results on hyperandrogenism
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
For those with obesity-related health conditions, Mounjaro may help reduce the risks associated with excessive weight, such as cardiovascular disease, stroke, or sleep apnea
At 4,114 Daltons (semaglutide) and 4,813 Daltons (tirzepatide), GLP-1 agonists are 8 to 10 times larger than the typical threshold for easy milk transfer
